How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Arthur Gies Arthur Gies is an editor for Wirecutter's tech coverage. He's ...

Versus Systems Inc. provides a business-to-business software platform to drive user engagement through gamification and rewards. The company offers the eXtreme Engagement Online platform, which is ...

May 22, 2026 Scientists have uncovered a strange hidden structure formed during the creation of metallocenes, a class of sandwich-like molecules used in everything from catalysis to medicine. The ...